NFE2L2 and obesity disorder: This study ultimately demonstrates that Serpina3c interacts with the intracellular binding protein Nrf2 in adipocytes to inhibit the Hif1α-glycolysis axis, thereby alleviating obesity-related hypertriglyceridemia and metabolic inflammation.